Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
49.82
+1.06 (2.17%)
At close: Jul 2, 2026, 4:00 PM EDT
49.97
+0.15 (0.30%)
After-hours: Jul 2, 2026, 5:36 PM EDT
Enliven Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $60 → $80 | Buy | Maintains | $60 → $80 | +60.58% | Jul 1, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $45 → $70 | Buy | Reiterates | $45 → $70 | +40.51% | Jun 29, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $59 | Buy | Maintains | $59 | +18.43% | Jun 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 12, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $80 | Buy | Maintains | $80 | +60.58% | Jun 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $60 | Buy | Reiterates | $60 | +20.43% | Jun 11, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $41 → $59 | Buy | Maintains | $41 → $59 | +18.43% | Jun 5, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $45 → $62 | Buy | Maintains | $45 → $62 | +24.45% | Jun 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.